company background image
CLV

Clover ASX:CLV Stock Report

Last Price

AU$1.09

Market Cap

AU$180.6m

7D

-1.4%

1Y

-35.0%

Updated

19 Aug, 2022

Data

Company Financials +
CLV fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends0/6

CLV Stock Overview

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas.

Clover Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Clover
Historical stock prices
Current Share PriceAU$1.09
52 Week HighAU$1.80
52 Week LowAU$0.95
Beta0.80
1 Month Change5.85%
3 Month Change-17.80%
1 Year Change-35.03%
3 Year Change-51.78%
5 Year Change133.33%
Change since IPO210.00%

Recent News & Updates

Jun 07
Here's Why Clover (ASX:CLV) Can Manage Its Debt Responsibly

Here's Why Clover (ASX:CLV) Can Manage Its Debt Responsibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Shareholder Returns

CLVAU ChemicalsAU Market
7D-1.4%-0.9%0.8%
1Y-35.0%10.5%-4.9%

Return vs Industry: CLV underperformed the Australian Chemicals industry which returned 10.5% over the past year.

Return vs Market: CLV underperformed the Australian Market which returned -4.9% over the past year.

Price Volatility

Is CLV's price volatile compared to industry and market?
CLV volatility
CLV Average Weekly Movement6.9%
Chemicals Industry Average Movement11.9%
Market Average Movement10.5%
10% most volatile stocks in AU Market17.8%
10% least volatile stocks in AU Market4.6%

Stable Share Price: CLV is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: CLV's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198853Peter Daveyhttps://www.clovercorp.com.au

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. The company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications.

Clover Fundamentals Summary

How do Clover's earnings and revenue compare to its market cap?
CLV fundamental statistics
Market CapAU$180.59m
Earnings (TTM)AU$5.50m
Revenue (TTM)AU$60.79m

32.8x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CLV income statement (TTM)
RevenueAU$60.79m
Cost of RevenueAU$42.39m
Gross ProfitAU$18.39m
Other ExpensesAU$12.89m
EarningsAU$5.50m

Last Reported Earnings

Jan 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.033
Gross Margin30.26%
Net Profit Margin9.05%
Debt/Equity Ratio20.4%

How did CLV perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

30%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is CLV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLV?

Other financial metrics that can be useful for relative valuation.

CLV key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.1x
Enterprise Value/EBITDA20.5x
PEG Ratio1.2x

Price to Earnings Ratio vs Peers

How does CLV's PE Ratio compare to its peers?

CLV PE Ratio vs Peers
The above table shows the PE ratio for CLV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average30.1x
ANO Advance ZincTek
72.8xn/aAU$159.4m
DGL DGL Group
14.5x-2.7%AU$765.1m
ZNO Zoono Group
29.9xn/aAU$22.5m
BRL Bathurst Resources
3xn/aAU$183.7m
CLV Clover
32.8x26.6%AU$180.6m

Price-To-Earnings vs Peers: CLV is expensive based on its Price-To-Earnings Ratio (32.8x) compared to the peer average (30.1x).


Price to Earnings Ratio vs Industry

How does CLV's PE Ratio compare vs other companies in the Global Chemicals Industry?

Price-To-Earnings vs Industry: CLV is expensive based on its Price-To-Earnings Ratio (32.8x) compared to the Global Chemicals industry average (16.2x)


Price to Earnings Ratio vs Fair Ratio

What is CLV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLV PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.8x
Fair PE Ratio20.4x

Price-To-Earnings vs Fair Ratio: CLV is expensive based on its Price-To-Earnings Ratio (32.8x) compared to the estimated Fair Price-To-Earnings Ratio (20.4x).


Share Price vs Fair Value

What is the Fair Price of CLV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLV (A$1.09) is trading above our estimate of fair value (A$0.34)

Significantly Below Fair Value: CLV is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Clover forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


26.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLV's forecast earnings growth (26.6% per year) is above the savings rate (1.8%).

Earnings vs Market: CLV's earnings (26.6% per year) are forecast to grow faster than the Australian market (6.2% per year).

High Growth Earnings: CLV's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CLV's revenue (16.3% per year) is forecast to grow faster than the Australian market (5% per year).

High Growth Revenue: CLV's revenue (16.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CLV's Return on Equity is forecast to be low in 3 years time (12.6%).


Discover growth companies

Past Performance

How has Clover performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


12.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CLV has high quality earnings.

Growing Profit Margin: CLV's current net profit margins (9%) are lower than last year (12.9%).


Past Earnings Growth Analysis

Earnings Trend: CLV's earnings have grown by 12.2% per year over the past 5 years.

Accelerating Growth: CLV's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CLV had negative earnings growth (-46.9%) over the past year, making it difficult to compare to the Chemicals industry average (196.9%).


Return on Equity

High ROE: CLV's Return on Equity (9.3%) is considered low.


Discover strong past performing companies

Financial Health

How is Clover's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: CLV's short term assets (A$54.5M) exceed its short term liabilities (A$7.9M).

Long Term Liabilities: CLV's short term assets (A$54.5M) exceed its long term liabilities (A$11.5M).


Debt to Equity History and Analysis

Debt Level: CLV's net debt to equity ratio (7%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if CLV's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: CLV's debt is well covered by operating cash flow (27.3%).

Interest Coverage: CLV's interest payments on its debt are well covered by EBIT (20.6x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Clover current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


0.92%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: CLV's dividend (0.92%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.63%).

High Dividend: CLV's dividend (0.92%) is low compared to the top 25% of dividend payers in the Australian market (6.42%).


Stability and Growth of Payments

Stable Dividend: CLV is not paying a notable dividend for the Australian market, therefore no need to check if payments are stable.

Growing Dividend: CLV is not paying a notable dividend for the Australian market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: CLV is not paying a notable dividend for the Australian market.


Cash Payout to Shareholders

Cash Flow Coverage: CLV is not paying a notable dividend for the Australian market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.3yrs

Average management tenure


CEO

Peter Davey

7.75yrs

Tenure

AU$602,204

Compensation

Mr. Peter J. Davey, MBA, GradDip Bus., Dip Art(Design), GAICD, has been Chief Executive Officer and Managing Director of Clover Corporation Limited since November 11, 2014. Mr. Davey has held senior manage...


CEO Compensation Analysis

Compensation vs Market: Peter's total compensation ($USD418.49K) is above average for companies of similar size in the Australian market ($USD280.16K).

Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CLV's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

Experienced Board: CLV's board of directors are considered experienced (6.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Clover Corporation Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Clover Corporation Limited
  • Ticker: CLV
  • Exchange: ASX
  • Founded: 1988
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Implied Market Cap: AU$180.587m
  • Shares outstanding: 166.44m
  • Website: https://www.clovercorp.com.au

Number of Employees


Location

  • Clover Corporation Limited
  • 39 Pinnacle Road
  • Altona North
  • Victoria
  • 3025
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/19 00:00
End of Day Share Price2022/08/19 00:00
Earnings2022/01/31
Annual Earnings2021/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.